[go: up one dir, main page]

BR9509122A - Composição para controlar do hábito de fumar processo para controle do desejo de fumar uso da composição e agente para controle do hábito de fumar - Google Patents

Composição para controlar do hábito de fumar processo para controle do desejo de fumar uso da composição e agente para controle do hábito de fumar

Info

Publication number
BR9509122A
BR9509122A BR9509122A BR9509122A BR9509122A BR 9509122 A BR9509122 A BR 9509122A BR 9509122 A BR9509122 A BR 9509122A BR 9509122 A BR9509122 A BR 9509122A BR 9509122 A BR9509122 A BR 9509122A
Authority
BR
Brazil
Prior art keywords
control
composition
smoking habit
desire
agent
Prior art date
Application number
BR9509122A
Other languages
English (en)
Inventor
Michael Glenn King
Original Assignee
Michael Glenn King
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michael Glenn King filed Critical Michael Glenn King
Publication of BR9509122A publication Critical patent/BR9509122A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/42—Phosphorus; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Psychiatry (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
BR9509122A 1994-09-23 1995-09-21 Composição para controlar do hábito de fumar processo para controle do desejo de fumar uso da composição e agente para controle do hábito de fumar BR9509122A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPM8353A AUPM835394A0 (en) 1994-09-23 1994-09-23 Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
PCT/AU1995/000621 WO1996009042A1 (en) 1994-09-23 1995-09-21 Compositions and methods for the control of smoking

Publications (1)

Publication Number Publication Date
BR9509122A true BR9509122A (pt) 1997-09-02

Family

ID=3782872

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9509122A BR9509122A (pt) 1994-09-23 1995-09-21 Composição para controlar do hábito de fumar processo para controle do desejo de fumar uso da composição e agente para controle do hábito de fumar

Country Status (10)

Country Link
US (3) US5883137A (pt)
EP (1) EP0777473A4 (pt)
JP (1) JP3989538B2 (pt)
CN (1) CN1117562C (pt)
AU (3) AUPM835394A0 (pt)
BR (1) BR9509122A (pt)
CA (1) CA2200755A1 (pt)
MX (1) MX9702163A (pt)
NZ (1) NZ293203A (pt)
WO (1) WO1996009042A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5965625A (en) * 1997-03-21 1999-10-12 King; Michael Glenn Compositions and methods for the control of smoking
AUPO897997A0 (en) * 1997-09-04 1997-09-25 King, Michael Glenn Improved compositions and methods for the control of smoking
FR2771639B1 (fr) * 1997-12-03 2000-05-05 Sod Conseils Rech Applic Utilisation d'extraits de ginkgo biloba pour preparer un medicament destine a faciliter le sevrage d'individus dependants de la consommation d'une substance engendrant une dependance et/ou une addiction
EP1055408A1 (de) * 1999-05-26 2000-11-29 Nutrinova Nutrition Specialties & Food Ingredients GmbH Sorbatkonservierte Mittel, Verfahren zu deren Herstellung und ihre Verwendung
JP4585066B2 (ja) * 1999-10-19 2010-11-24 丸善製薬株式会社 う蝕防止剤、口腔用剤および飲食物
US20050037073A1 (en) * 2000-01-13 2005-02-17 Alpharx Inc. Solid self-emulsifying dosage form for improved delivery of poorly soluble hydrophobic compounds and the process for preparation thereof
US6789546B2 (en) * 2001-06-26 2004-09-14 Technion Research & Development Foundation Ltd. Filters for preventing or reducing tobacco smoke-associated injury in the aerodigestive tract of a subject
WO2003052050A2 (en) * 2001-08-03 2003-06-26 Diversa Corporation P450 enzymes, nucleic acids encoding them and methods of making and using them
JP2003261448A (ja) * 2002-03-07 2003-09-16 Japan Science & Technology Corp 抗腫瘍剤
EP1883405A4 (en) * 2005-05-09 2010-01-27 Takeda Pharmaceuticals North A METHODS OF TREATING NEPHROLITHIASIS
US20070134169A1 (en) * 2005-12-11 2007-06-14 Rabinoff Michael D Methods for smoking cessation or alcohol cessation or other addiction cessation
MX2009004984A (es) * 2006-11-13 2009-09-23 Takeda Pharmaceuticals North A Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
US20090124623A1 (en) * 2006-11-13 2009-05-14 Christopher Lademacher Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
US20090042887A1 (en) * 2007-01-19 2009-02-12 Tap Pharmaceutical Products, Inc. Methods for Preventing or Reducing the Number of Gout Flares Using Xanthine Oxidoreductase Inhibitors and Anti-Inflammatory Agents
US20100311756A1 (en) * 2009-01-22 2010-12-09 Takeda Pharmaceuticals North America, Inc. Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
DK2515918T3 (en) * 2009-12-21 2015-01-12 Rcp Dev Inc SMOKING SUGAR TABLET CONTAINING TOBACCO ALKALOID AND SILVER SALT
EP2613780B1 (en) 2010-09-10 2014-11-12 Takeda Pharmaceuticals U.S.A., Inc. Methods for concomitant treatment of theophylline and febuxostat

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE16150T1 (de) 1979-11-10 1985-11-15 Siegfried Ag Xanthinoxydasehemmer und verwendung von benztriazinderivaten.
JPS63203624A (ja) * 1987-02-18 1988-08-23 Katsumi Mizumaki 喫煙を止めるための薬剤
JPS6440432A (en) * 1987-08-04 1989-02-10 Tadao Inagaki Solution making people come to dislike smoking
US4997671A (en) * 1988-09-09 1991-03-05 Nabisco Brands, Inc. Chewy dog snacks
JPH03161463A (ja) 1989-11-20 1991-07-11 Gunze Ltd キサンチンオキシダーゼ阻害剤
JP2924099B2 (ja) * 1990-06-13 1999-07-26 茂 川瀬 経口節煙剤
GB9200047D0 (en) * 1992-01-03 1992-02-26 Univ Alberta Nicotine-containing nasal spray
US5612357A (en) * 1992-05-18 1997-03-18 Pharmaco Behavioral Associates, Inc. Use of cotinine to assist in the cessation of tobacco smoking
US5362496A (en) * 1993-08-04 1994-11-08 Pharmetrix Corporation Method and therapeutic system for smoking cessation
AU7438894A (en) * 1993-10-05 1995-04-27 Michael Glenn King Method for the treatment of diseases caused by compromised xanthine metabolism and methods for detecting said diseases
US5614501A (en) * 1994-07-21 1997-03-25 The University Of Montana Compositions and methods for animal husbandry and for treating gastrointestinal disorders
AUPM835394A0 (en) * 1994-09-23 1994-10-13 King, Michael G. Dr. Method for controlling or eliminating the need to smoke tobacco, and for treating ailments which may lead to the said need
US5965625A (en) 1997-03-21 1999-10-12 King; Michael Glenn Compositions and methods for the control of smoking

Also Published As

Publication number Publication date
US20020028775A1 (en) 2002-03-07
US5883137A (en) 1999-03-16
AU671577B3 (en) 1996-08-29
EP0777473A4 (en) 2002-08-21
AU713613B2 (en) 1999-12-09
JPH10505841A (ja) 1998-06-09
MX9702163A (es) 1997-06-28
CN1161647A (zh) 1997-10-08
US6288087B1 (en) 2001-09-11
AUPM835394A0 (en) 1994-10-13
JP3989538B2 (ja) 2007-10-10
US6749870B2 (en) 2004-06-15
WO1996009042A1 (en) 1996-03-28
EP0777473A1 (en) 1997-06-11
AU3558795A (en) 1996-04-09
CA2200755A1 (en) 1996-03-28
NZ293203A (en) 1998-05-27
CN1117562C (zh) 2003-08-13

Similar Documents

Publication Publication Date Title
BR9509122A (pt) Composição para controlar do hábito de fumar processo para controle do desejo de fumar uso da composição e agente para controle do hábito de fumar
FI962828L (fi) Monometasonifuroaatin käyttö ilmantiehye- ja keuhkosairauksien hoitamiseksi
BR8706704A (pt) Agente modificador de impacto para utilizacao com artigos de fumar
BR9500555A (pt) Composição cosméticas de uso tópico,processo de preparação de composições,utilização de composições e processo de tratamento cosmético
FI972781L (fi) Menetelmät ja koostumukset allergisen nuhan ja muiden sairauksien hoitamiseksi käyttäen dekarboetokyloratadieeniä
FI883055A7 (fi) Deodoroiva ja antimikrobinen koostumus käytettäväksi kosmeettisissa tai paikallisesti käytettävissä valmisteissa.
FI971969L (fi) Peräpukamien hoitoon tarkoitettuja koostumuksia ja käyttömenetelmä
FI970240L (fi) Vaahtoamaan kykenevä vesipitoinen koostumus
FI923548A7 (fi) Vaahtoa muodostava koostumus farmaseuttiseen käyttöön, sen käyttö ja h oitomenetelmä
FI943173L (fi) Koostumus tupakoinnin lopettamisen auttamiseksi
EE04047B1 (et) Sidovudiini, 1592U89 ja 3TC või FTC sünergistlikud kombinatsioonid
PL315941A1 (en) 4-heterocyclic substituted derivatives of quinazoline, methods of obtaining them and their application as anticarcinogenic agents
BR9607808A (pt) Composição para limpeza da pele e processo para realçar o efeito antimicrobiano das formulações para limpeza da pele
BR9800344A (pt) Composição de vidro e utilização das composições de vidro
EE03304B1 (et) Tsüklodekstriini või selle derivaadi kasutamine mukoadhesiivse ainena, mukoadhesiivne kompositsioon ja meetod selle valmistamiseks
FI892410A7 (fi) Uusi saostunut absorboiva piidioksidi ja sen peruskoostumus
BR8705636A (pt) Composicao sinergica e processo para o combate seletivo de ervas daninhas no arroz e aplicacao
ID17437A (id) Metoda dan komposisi untuk membuat kulit terang
HUT77794A (hu) Tiofénkarboxamidszármazék és alkalmazása növények torzsgomba (take-all) betegségének kezelésére
BR8700021A (pt) Material envoltorio para haste de fumar e haste de fumar
FI962908A0 (fi) Mikrobinvastainen koostumus, sen valmistusmenetelmMikrobinvastainen koostumus, sen valmistusmenetelmä ja sen käyttö ä ja sen käyttö
BR9408425A (pt) Sílica, seu processo de preparação utilização da sílica e composição dentifrícia
BR9602680A (pt) Uso de uma composição para o tratamento da pele e agente para o tratamento da pele
FI964031L (fi) Bentsamidijohdannainen, mainittua johdannaista sisältävät koostumukset ja sen käyttö
FI950290A7 (fi) Uusia bioaktiivisia koostumuksia, niiden valmistus ja käyttö

Legal Events

Date Code Title Description
FB36 Technical and formal requirements: requirement - article 36 of industrial property law
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B11B Dismissal acc. art. 36, par 1 of ipl - no reply within 90 days to fullfil the necessary requirements
B15K Others concerning applications: alteration of classification

Free format text: PROCEDIMENTO AUTOMATICO DE RECLASSIFICACAO. AS CLASSIFICACOES IPC ANTERIORES ERAM: A61K 31/35; A61K 31/70; A61K 33/42; A61K 35/02; A61K 35/78.

Ipc: A61K 33/42 (2006.01), A61K 36/28 (2006.01), A61K 4

Ipc: A61K 33/42 (2006.01), A61K 36/28 (2006.01), A61K 4